Health-care companies ticked down as traders rotated out of defensive sectors into technology companies.
Earnings were mixed. Moderna shares fell after the biotech firm said a late-stage trial of its norovirus vaccine candidate didn't meet the criteria for early success in an interim analysis of trial data. AbbVie cut its full-year adjusted earnings outlook to account for its acquisition of Apogee Therapeutics, as the company logged higher profit and revenue in the recent quarter.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
July 31, 2026 17:13 ET (21:13 GMT)
